Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
7.24
+0.21 (2.99%)
At close: Apr 28, 2026, 4:00 PM EDT
7.24
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:11 PM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $759.39 million as of April 28, 2026. Its market cap has increased by 7,893.59% in one year.

Market Cap
759.39M
Enterprise Value
666.38M
1-Year Change
7,893.59%
Ranking
Category
Stock Price
$7.24

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $759.39M, an increase of 1,241.68%. That is a compound annual growth rate of 27.81%.

History

DateMarket Cap% Change
Apr 27, 2026737.40M108.19%
Dec 31, 2025354.20M2,156.05%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition